Roche Third Quarter Sales Slightly Beat Expectations with Growth Across Divisions

Roche posts higher sales on growth scross pharma, diagnostics units

Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.

Roche third-quarter sales beat forecast with growth across divisions, currency boost

Roche third quarter sales slightly beat expectations with growth across divisions

ZURICH/ LONDON, Oct 22 - Roche sales ​rose ‌in the third quarter, the Swiss ‌drugmaker ​said ⁠on Thursday, ⁠slightly beating analyst expectations. With growth in both ​its pharmaceuticals and ⁠diagnostics ⁠divisions, group ​sales came ​in at 16.13 ‌bil...

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine […] - PressReach

Ad hoc announcement pursuant to Art. 53 LR Basel, 22 October 2026 Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine months of 2026 Group sales were +6% at constant … Continue reading "[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at …

Roche Q3 sales rise 8% to CHF 16.1B

Roche Holding AG said on Thursday that its sales increased 8% year on year to CHF 16.13 billion in the third quarter of 2026. At constant exchange rates, sales grew 7%, or 6% excluding a positive timi...